ArticleExperimental and therapeutic medicine2021

Dihydroartemisinin inhibits endothelial cell migration via the TGF-β1/ALK5/SMAD2 signaling pathway.

Ling Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.